A trial looking at selumetinib for thyroid cancer that has stopped taking up radioactive iodine (SEL-I-METRY).
The Selimetry trial is now open at the Royal Marsden and more centres will be open soon.
Read more here.
Please leave a message on our answer phone and we will get back to you as soon as we can.
Email: amy@butterfly.org.uk
Scan our QR code to donate today!
Excellence in Oncology
'Bright Ideas'
Highly Recommended
